Rxsight Correlations
RXST Stock | USD 45.05 0.24 0.54% |
The current 90-days correlation between Rxsight and Axogen Inc is 0.28 (i.e., Modest diversification). The correlation of Rxsight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Rxsight Correlation With Market
Very weak diversification
The correlation between Rxsight and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rxsight and DJI in the same portfolio, assuming nothing else is changed.
Rxsight |
Moving together with Rxsight Stock
0.74 | AGL | agilon health | PairCorr |
0.89 | AMN | AMN Healthcare Services | PairCorr |
0.75 | FORA | Forian Inc | PairCorr |
0.83 | EVH | Evolent Health | PairCorr |
0.66 | IVP | Inspire Veterinary | PairCorr |
0.66 | ADUS | Addus HomeCare | PairCorr |
0.72 | BACK | IMAC Holdings | PairCorr |
0.63 | CYRX | Cryoport | PairCorr |
0.84 | VALN | Valneva SE ADR | PairCorr |
0.7 | VCNX | Vaccinex | PairCorr |
Moving against Rxsight Stock
0.82 | DOCS | Doximity | PairCorr |
0.6 | FOXO | FOXO Technologies | PairCorr |
0.55 | VMD | Viemed Healthcare | PairCorr |
0.54 | ITGR | Integer Holdings Corp | PairCorr |
0.72 | OMIC | Singular Genomics Systems | PairCorr |
0.57 | CRVL | CorVel Corp Normal Trading | PairCorr |
0.53 | MMSI | Merit Medical Systems | PairCorr |
0.42 | NXGL | Nexgel Inc | PairCorr |
0.81 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.65 | EWTX | Edgewise Therapeutics | PairCorr |
0.54 | EXEL | Exelixis | PairCorr |
0.54 | KZR | Kezar Life Sciences | PairCorr |
0.52 | VRDN | Viridian Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Rxsight Stock performing well and Rxsight Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rxsight's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
AXGN | 2.25 | (0.05) | (0.01) | 0.06 | 3.80 | 4.73 | 21.60 | |||
TMCI | 3.16 | (0.01) | 0.11 | 0.10 | 2.76 | 6.08 | 38.73 | |||
LUNG | 3.25 | (0.30) | 0.00 | (0.04) | 0.00 | 9.00 | 20.52 | |||
OFIX | 1.86 | 0.06 | 0.04 | 0.14 | 2.04 | 3.90 | 12.11 | |||
KIDS | 2.61 | (0.36) | 0.00 | (0.15) | 0.00 | 5.04 | 19.39 | |||
SGHT | 3.06 | (1.05) | 0.00 | (0.22) | 0.00 | 6.96 | 18.22 | |||
FNA | 3.85 | 0.27 | 0.11 | 0.19 | 4.04 | 7.83 | 43.16 | |||
SSKN | 3.08 | 0.22 | 0.05 | 0.39 | 3.83 | 8.83 | 20.44 | |||
NPCE | 3.44 | 0.17 | 0.09 | 0.17 | 3.21 | 9.73 | 35.38 | |||
VAPO | 4.98 | (0.37) | 0.00 | (0.16) | 0.00 | 15.38 | 34.31 |
Rxsight Corporate Management
Matt Haller | Chief Officer | Profile | |
Alex Huang | Investor Relations | Profile | |
Oliver Moravcevic | Vice Relations | Profile | |
Scott Gaines | Senior Process | Profile | |
Caroline Vaughn | Vice Resources | Profile |